FAXnewsletter copia - Mondobiotech

mondoBIOTECH holding AG (SIX: RARE): Exclusive
engagement with financial services firm WR Hambrecht +
Co., LLC.
Stans, 21 April 2010. mondoBIOTECH holding AG (SIX: RARE) announces
exclusive engagement with prominent Silicon Valley financial services firm WR
Hambrecht + Co.
Mondobiotech CEO Fabio Cavalli and President of WR Hambrecht + Co.
Elizabeth Hambrecht announce today an agreement establishing Hambrecht
as the exclusive placement agent for Mondobiotech’s securities. The
relationship brings the innovative and extensive experience of WR Hambrecht
in Silicon Valley financing to the innovative Mondobiotech mission and
methods discovering and making available new therapies for the treatment of
rare diseases.
WR Hambrecht + Co. will advise and assist the company in the preparation of
strategies and documentation as well as the identification of and contracting
with prospective purchasers of Mondobiotech securities.
WR Hambrecht + Co. has assigned a team of analysts, market strategists, and
senior executives, led by Elizabeth Hambrecht herself to work with officers
and board members of mondoBIOTECH holding AG to accomplish these tasks
and implement the strategic placements contemplated by the agreement.
This agreement is another step in the realization of the mission of
Mondobiotech to support and to engage communities of patients with rare
diseases, their families, and their physicians. It is expected that the
engagement of WR Hambrecht + Co. should provide for the material
expansion of Mondobiotech’s therapeutic pipelines for the direct benefit of
people suffering from rare diseases.
Founded in 1998 by William R. Hambrecht, WR Hambrecht + Co. is a financial
services firm committed to using technology and auction processes to
provide open and fair access to financial markets for all its clients. The firm’s
impartial auctions, which allow the market to determine pricing and
allocation, are dramatically changing the financial services landscape. WR
Hambrecht + Co. is headquartered in San Francisco with offices in New York
and Philadelphia. http://www.wrhambrecht.com/
Page 1 of 3

About Mondobiotech
mondoBIOTECH holding AG (SIX Swiss Exchange ticker symbol: RARE), an
independent, internet-based biotech research company, discovers drugs for
patients suffering from rare and neglected diseases. Mondobiotech has built
a continuously growing global community of biologists, biochemists,
physicians, patients and patient advocacy organizations who share their
passion and skills with Mondobiotech. Together with Mondobiotech, this
community is searching for treatments for rare and neglected diseases.
For further information please contact:
mondoBIOTECH holding AG
Das Kloster
Mürgstrasse 18
CH-6370 Stans
Tel.: +41 (0) 840 200 010
Fax: +41 (0) 840 200 011
investor@mondobiotech.com
www.mondobiotech.com
Disclaimer
The foregoing release may contain forward-looking statements. The words
“anticipates”, “believes”, “estimates”, “expects”, “intends”, “may”, “plans”,
“projects”, “will”, “would” and similar expressions are intended to identify
forward-looking statements, although not all forward-looking statements
contain these identifying words. mondoBIOTECH holding AG may not achieve
the plans, intentions or expectations disclosed in its forward-looking
statements and prospective investors should not place reliance on
mondoBIOTECH holding AG’s forward looking statements. There can be no
assurance that results of the activities and results of operations will not differ
materially from the expectations. Forward- looking statements are subject to
inherent risks and uncertainties, some of which cannot be predicted or
quantified. Future events and actual results could differ materially from those
set forth in, contemplated by or underlying the forward looking statements.
mondoBIOTECH holding AG is providing the information in this press release
as of this date and does not undertake any obligation to update any forward-
looking statements contained in this press release as a result of new
information, future events or otherwise.
Personal Information
This email is from mondoBIOTECH holding AG. The email and any files
transmitted with it are intended solely for the use of the individual or entity to
Page 2 of 3

which they are addressed. Any unauthorized dissemination or copying of this
email or its attachments, is strictly prohibited and may be illegal. If you have
received the email in error please delete it from your system.
Page 3 of 3